ENMANUEL CASTRO FERNANDEZ: Open Payments
NPI 1225814080 · RIVERVIEW, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$486 in 24 payments from 14 companies in 2025. Trend: 2023 $95 · 2024 $901 · 2025 $486
Food & beverage: $486
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 6 | $109 |
| Ascendis Pharma Endocrinology Inc | 3 | $67 |
| ABBVIE INC. | 2 | $45 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
| Lilly USA, LLC | 2 | $39 |
| Radius Health, Inc. | 1 | $28 |
| Rhythm Pharmaceuticals, Inc. | 1 | $27 |
| SANOFI-AVENTIS U.S. LLC | 1 | $26 |
| Exact Sciences Corporation | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
Products named: Korlym, Yorvipath, VRAYLAR, Kerendia, MOUNJARO, Tymlos, IMCIVREE, TZIELD.
Industry payments across FL — which companies pay providers there.
